These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

789 related articles for article (PubMed ID: 10749912)

  • 1. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.
    Esteller M; Silva JM; Dominguez G; Bonilla F; Matias-Guiu X; Lerma E; Bussaglia E; Prat J; Harkes IC; Repasky EA; Gabrielson E; Schutte M; Baylin SB; Herman JG
    J Natl Cancer Inst; 2000 Apr; 92(7):564-9. PubMed ID: 10749912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study.
    Baldwin RL; Nemeth E; Tran H; Shvartsman H; Cass I; Narod S; Karlan BY
    Cancer Res; 2000 Oct; 60(19):5329-33. PubMed ID: 11034065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation not a frequent "second hit" in tumors with germline BRCA mutations.
    Dworkin AM; Spearman AD; Tseng SY; Sweet K; Toland AE
    Fam Cancer; 2009; 8(4):339-46. PubMed ID: 19340607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
    Potapova A; Hoffman AM; Godwin AK; Al-Saleem T; Cairns P
    Cancer Res; 2008 Feb; 68(4):998-1002. PubMed ID: 18281473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas.
    Virmani AK; Rathi A; Sathyanarayana UG; Padar A; Huang CX; Cunnigham HT; Farinas AJ; Milchgrub S; Euhus DM; Gilcrease M; Herman J; Minna JD; Gazdar AF
    Clin Cancer Res; 2001 Jul; 7(7):1998-2004. PubMed ID: 11448917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-hit inactivation of FHIT by loss of heterozygosity and hypermethylation in breast cancer.
    Yang Q; Nakamura M; Nakamura Y; Yoshimura G; Suzuma T; Umemura T; Shimizu Y; Mori I; Sakurai T; Kakudo K
    Clin Cancer Res; 2002 Sep; 8(9):2890-3. PubMed ID: 12231533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of the BRCA1 gene in sporadic breast cancer.
    Dobrovic A; Simpfendorfer D
    Cancer Res; 1997 Aug; 57(16):3347-50. PubMed ID: 9269993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of BRCA1 dysfunction in ovarian cancer.
    Geisler JP; Hatterman-Zogg MA; Rathe JA; Buller RE
    J Natl Cancer Inst; 2002 Jan; 94(1):61-7. PubMed ID: 11773283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer.
    Bianco T; Chenevix-Trench G; Walsh DC; Cooper JE; Dobrovic A
    Carcinogenesis; 2000 Feb; 21(2):147-51. PubMed ID: 10657950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter hypermethylation and post-transcriptional mechanisms for reduced BRCA1 immunoreactivity in sporadic human breast cancers.
    Miyamoto K; Fukutomi T; Asada K; Wakazono K; Tsuda H; Asahara T; Sugimura T; Ushijima T
    Jpn J Clin Oncol; 2002 Mar; 32(3):79-84. PubMed ID: 11956301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene.
    Wang C; Horiuchi A; Imai T; Ohira S; Itoh K; Nikaido T; Katsuyama Y; Konishi I
    J Pathol; 2004 Feb; 202(2):215-23. PubMed ID: 14743504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity on chromosome 13q12-q14, BRCA-2 mutations and lack of BRCA-2 promoter hypermethylation in sporadic epithelial ovarian tumors.
    Gras E; Cortes J; Diez O; Alonso C; Matias-Guiu X; Baiget M; Prat J
    Cancer; 2001 Aug; 92(4):787-95. PubMed ID: 11550149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High frequency of allelic loss at the BRCA1 locus in ovarian cancers: clinicopathologic and molecular associations.
    Rzepecka IK; Szafron L; Stys A; Bujko M; Plisiecka-Halasa J; Madry R; Osuch B; Markowska J; Bidzinski M; Kupryjanczyk J
    Cancer Genet; 2012 Mar; 205(3):94-100. PubMed ID: 22469508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
    Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel somatic mutations in the BRCA1 gene in sporadic breast tumors.
    Janatova M; Zikan M; Dundr P; Matous B; Pohlreich P
    Hum Mutat; 2005 Mar; 25(3):319. PubMed ID: 15712267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
    Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
    Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers.
    Maxwell KN; Wubbenhorst B; Wenz BM; De Sloover D; Pluta J; Emery L; Barrett A; Kraya AA; Anastopoulos IN; Yu S; Jiang Y; Chen H; Zhang NR; Hackman N; D'Andrea K; Daber R; Morrissette JJD; Mitra N; Feldman M; Domchek SM; Nathanson KL
    Nat Commun; 2017 Aug; 8(1):319. PubMed ID: 28831036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of BRCA1 and BRCA2 in ovarian cancer.
    Hilton JL; Geisler JP; Rathe JA; Hattermann-Zogg MA; DeYoung B; Buller RE
    J Natl Cancer Inst; 2002 Sep; 94(18):1396-406. PubMed ID: 12237285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of epigenetic alteration of BRCA1 and BRCA2 genes in breast carcinomas in Tunisian patients.
    Ben Gacem R; Hachana M; Ziadi S; Amara K; Ksia F; Mokni M; Trimeche M
    Cancer Epidemiol; 2012 Apr; 36(2):190-7. PubMed ID: 21978880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sporadic breast carcinomas with somatic BRCA1 gene deletions share genotype/phenotype features with familial breast carcinomas.
    Rhiem K; Todt U; Wappenschmidt B; Klein A; Wardelmann E; Schmutzler RK
    Anticancer Res; 2010 Sep; 30(9):3445-9. PubMed ID: 20944121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.